US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

29.07

+0.15740.54%

Post-market: 29.070.00000.00%16:10 EDT

Volume:505

Turnover:14.70K

Market Cap:1.02M

PE:- -

High:29.07

Open:28.99

Low:28.99

Close:28.92

52wk High:29.88

52wk Low:24.32

Shares:35.00K

Float Shares:35.00K

Volume Ratio:1.32

T/O Rate:1.44%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says

THOMSON REUTERS

Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says

THOMSON REUTERS

Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Benzinga Earnings

Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth

Enanta Pharmaceuticals Q3 Revenue Misses Estimates, Hurt by Lower Royalties

Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss

MT Newswires Live

Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million

Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI

THOMSON REUTERS

Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers

THOMSON REUTERS

Hims & Hers Posts Higher Quarterly Revenue on Strong Subscriber Growth

Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate

Benzinga Earnings

Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33

THOMSON REUTERS

Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million

Hims & Hers Health Q2 EPS USD -0.37

THOMSON REUTERS

Hims & Hers Health, Inc. Q3 REV View $793.1 Mln

THOMSON REUTERS

Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda

THOMSON REUTERS

Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year

THOMSON REUTERS

Enanta FY26 Q3 Net Loss Widens to $19.5 Million; Revenue Falls to $14.4 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/GLAM/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":29.073,"timestamp":1787601600000,"preClose":28.9156,"halted":0,"volume":505,"hourTrading":{"tag":"盘后","latestPrice":29.073,"preClose":29.073,"latestTime":"16:10 EDT","volume":4,"amount":116.292,"timestamp":1787602204668,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005443428460761634,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Post-Mkt","change":0.1574,"latestTime":"08-24 19:01:06 EDT","open":28.99,"high":29.073,"low":28.99,"amount":14695,"amplitude":0.00287,"askPrice":43.5,"askSize":200,"bidPrice":14.5,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":28.9156,"nav":28.33,"aum":991550,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":29.93,"preClose":28.9156,"latestTime":"09:08 EDT","volume":4,"amount":119.72,"timestamp":1787576884616,"change":1.0144,"changeRate":0.035081,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":29.073,"preClose":29.073,"latestTime":"16:10 EDT","volume":4,"amount":116.292,"timestamp":1787602204668,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.321298,"impliedVol":0.2298,"impliedVolPercentile":0.0746},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.321298,"shares":35000,"dividePrice":0,"high":29.073,"amplitude":0.00287,"preClose":28.9156,"low":28.99,"week52Low":24.3178,"pbRate":"--","week52High":29.88,"institutionHeld":0,"latestPrice":29.073,"eps":0,"divideRate":0,"volume":505,"delay":0,"ttmEps":0,"open":28.99,"prevYearClose":25.82,"prevWeekClose":28.9156,"prevMonthClose":27.9767,"prevQuarterClose":27.6454,"fiveDayClose":27.6569,"twentyDayClose":28.248,"sixtyDayClose":24.7324},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658095467","title":"Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095467?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:00","pubTimestamp":1786395648,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, Inc. reports results for the quarter ended June 30 - Earnings SummaryHims & Hers Health, Inc.HIMS.Nreported a quarterly adjusted loss of 37 cents per share for the quarter ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4471Z2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","THNR","HIMY","HIMS","BK4196","HMYY","HEAL","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954585","title":"Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954585?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","HEAL","BK4196","HIMY","HIMZ","THNR","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951208","title":"Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951208?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","GLAM","HEAL","HMYY","HIMY","THNR","BK4196","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658519329","title":"Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658519329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658519329?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:31","pubTimestamp":1786393860,"startTime":"0","endTime":"0","summary":"Hims & Hers Health raised its revenue projections for the year, though higher costs swung it to a loss in the second quarter.The telehealth platform said it now projects $3.1 billion to $3.3 billion i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","BK4196","HIMZ","HIYY","THNR","GLAM","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658285959","title":"Hims & Hers Shares Drop After Mixed Q2 Earnings — Details","url":"https://stock-news.laohu8.com/highlight/detail?id=2658285959","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658285959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:17","pubTimestamp":1786393043,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers posted Q2 results - here are the details you need to know.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61092738/hims-hers-shares-drop-after-mixed-q2-earnings-details","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","BK4196","HIMZ","HIYY","THNR","GLAM","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959179","title":"Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959179","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959179?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:15","pubTimestamp":1786392909,"startTime":"0","endTime":"0","summary":"Telehealth platform Hims & Hers swings to Q2 net loss as margin pressure offsets revenue growthOverviewUS health platform's Q2 revenue rose 38% yr/yr, beating analyst expectationsCompany posted Q2 net","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","GLAM","HIMZ","HIMS","HEAL","BK4196","THNR","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959568","title":"Enanta Pharmaceuticals Q3 Revenue Misses Estimates, Hurt by Lower Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959568","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959568?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:10","pubTimestamp":1786392611,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royaltiesOverviewU.S. biotech firm's fiscal Q3 revenue fell and missed analyst expectationsCompany posted a wider net loss of $19.5 ml","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","LU2237443895.HKD","LU0795875169.SGD","BK4007","LU0289739343.SGD","SG9999003800.SGD","IYH","IE00BLSP4452.SGD","IE00BSNM7G36.USD","LU0912757837.SGD","PPH","GLAM","LU0256863902.USD","LU0289739699.SGD","FHLC","LU0738911758.USD","MEDX","IE0000B7K699.USD","AGNG","IE00BDGV0183.EUR","TBPH","IE00B42XCP33.USD","IE00B19Z3581.USD","ABBV","ENTA","LU2089984988.USD","LU0395794307.EUR","LU1244550494.USD","BK4139","LU1093756325.SGD","PJP","LU0861579265.USD","SG9999015952.SGD","FTXH","LU1934455863.HKD","IE000MB6IJN5.SGD","LU0057025933.USD","RXL","LU2087621335.USD","LU2237443382.USD","IXJ","LU0943347566.SGD","XLV","TRUH","JDOC","VHT","LU2237443978.SGD","IE00BJT1NW94.SGD","LU0320765646.SGD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995931","title":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995931","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995931?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392570,"startTime":"0","endTime":"0","summary":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HEAL","HIMS","THNR","HMYY","HIYY","HIMY","HIMZ","GLAM","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995959","title":"Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995959","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392559,"startTime":"0","endTime":"0","summary":"Hims & Hers Q2 FY26 net loss widens to $86.3 million; revenue rises 38% to $753.2 millionHims & Hers posted Q2 2026 revenue of USD 753.2 million, up 38% year-over-year; net results swung to a USD 86.3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL2PdtJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMZ","HMYY","HIYY","HIMS","HIMY","BK4196","THNR","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959334","title":"Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959334?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","GLAM","HEAL","HIYY","HIMS","HIMZ","THNR","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695934","title":"Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695934?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HIMY","THNR","BK4196","HMYY","HIMZ","HEAL","GLAM","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959350","title":"Hims & Hers Posts Higher Quarterly Revenue on Strong Subscriber Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959350","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959350?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392494,"startTime":"0","endTime":"0","summary":"Hims & Hers posts higher quarterly revenue on strong subscriber growthNEW YORK, Aug 10 -Hims & Hers HealthHIMS.Non Monday posted a rise in second-quarter revenue as the telehealth company benefited from an increase in subscribers and expanding its personalized healthcare offerings.The company reported revenue of $753 million during the quarter, compared with $544 million a year ago. Analysts were expecting a revenue of $699.89 million, per data compiled by LSEG.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4471ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMZ","HIMS","THNR","HIMY","HMYY","GLAM","BK4196","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959874","title":"Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959874","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959874?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392452,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.03) by 1133.33 percent. This is a 317.65 percent decrease over earnings of $0.17 per","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61091412/hims-hers-health-q2-eps-0-37-misses-0-03-estimate-sales-753-214m-beat-699-889m-estimate","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimat...","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HEAL","GLAM","HIMZ","THNR","HIYY","HIMY","HMYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2658598159","title":"Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2658598159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658598159?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392428,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL6N4470Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HEAL","BK4196","HIMY","HIYY","HIMZ","THNR","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959895","title":"Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959895","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959895?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:06","pubTimestamp":1786392361,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 MillionAug 10  - Hims & Hers Health Q2 net income USD -86.3 million.outlook FY revenue USD 3,100-3,300 million vs. IBES estimate USD 2,928 millionoutlook FY adjusted EBITDA USD 275-325 million vs. IBES estimate USD 296.2 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMZ","GLAM","HIMY","HIMS","HEAL","HMYY","BK4196","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959814","title":"Hims & Hers Health Q2 EPS USD -0.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959814?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIYY","HEAL","HIMY","HIMZ","HMYY","GLAM","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959546","title":"Hims & Hers Health, Inc. Q3 REV View $793.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959546?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","GLAM","HIMZ","BK4196","HEAL","HMYY","THNR","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956027","title":"Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956027?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMY","HIMS","BK4196","HIMZ","HIYY","THNR","GLAM","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658051956","title":"Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658051956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658051956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMZ","THNR","HEAL","HMYY","GLAM","HIMS","HIYY","BK4196","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956419","title":"Enanta FY26 Q3 Net Loss Widens to $19.5 Million; Revenue Falls to $14.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956419","media":"Reuters","labels":["policyRegulatory","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956419?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:02","pubTimestamp":1786392129,"startTime":"0","endTime":"0","summary":"Enanta FY26 Q3 net loss widens to $19.5 million; revenue falls to $14.4 millionEnanta posted fiscal Q3 revenue of USD 14.4 million, down 21.6% year over year, on lower AbbVie MAVYRET/MAVIRET net sales","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL47q05R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","AGNG","LU2129689514.USD","LU0211328371.USD","IXJ","LU1496350502.SGD","IE00BLSP4239.USD","VHT","LU1923622614.USD","LU1839511570.USD","IYH","LU0689472784.USD","IE0004445239.USD","FHLC","LU1585245621.USD","LU0256863811.USD","LU1929549753.HKD","XLV","IE00BLSP4452.SGD","JDOC","LU1496350171.SGD","TRUH","LU0289739699.SGD","LU0128525929.USD","LU0234570918.USD","LU1670628061.USD","LU0256863902.USD","ENTA","IE00B2B36J28.USD","LU1732800096.USD","LU1162221912.USD","PPH","PJP","LU0058720904.USD","LU1551013342.USD","FTXH","IE00B19Z3581.USD","LU1670627923.USD","LU1989772840.SGD","LU2237443895.HKD","GLAM","BK4139","IE00BN8TJ469.HKD","LU2237443549.SGD","RXL","LU1989771016.USD","LU0124676726.USD","LU0726765562.USD","ABBV","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}